Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

The requested reference [152eba6f6149ba07f594c26e2d01053256452bd6] no longer exists in our database. It has been replaced by the current reference: [6318667c97e890cc3ad67e36bb59f4ce4e0c172a]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
To compare efficacy and safety of Gemcitabine versus S-1 adjuvant therapy after hemihepatectomy.
Epistemonikos ID: 3b4b2627187bbb47e0ad76f596056f31c1db3cb3
First added on: May 11, 2024